Development and validation of assay method for benserazide hydrochloride active ingredient
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
Benserazide hydrochloride is a hydrochloride, monohydrochloride salt of benserazide. This compound is an aromatic-L-amino-acid decarboxylase inhibitor that does not enter the central nervous system and is used to treat parkinsonism as an adjunct to levodopa (Ulusal Biyoteknoloji Bilgi Merkezi, 2023). Parkinson's disease is a disorder of the nervous system and is caused by a deficiency of dopamine produced in the brain. Dopamine transmits messages in the part of the brain that controls muscle movements. If dopamine is produced too little, problems with movement occur. Levodopa crosses the blood-brain barrier and enters the brain where it can be converted into dopamine by certain nerve cells and is a pharmaceutical raw material that acts by increasing the level of dopamine in the brain (Pickover, 2012; Türkiye İlaç ve Tıbbi Cihaz Kurumu, 2016). Benserazide acts by increasing the amount of levodopa by inhibiting the conversion of levodopa to dopamine in the periphery. Levodopa and benserazide combination products used worldwide are widely used for the treatment of Parkinson's disease (Ulusal Biyoteknoloji Bilgi Merkezi, 2023). The aim of this study was to develop a new High Performance Liquid Chromatography (HPLC) method for assay of the active substance benserazide hydrochloride, which is not available in the literature. The developed analytical method was validated with validation parameters. In the developed method, the separation was achieved by creating a gradient program with Waters Symmetry C8 (4.6 mm x 150 mm, 3.5 µm), potassium dihydrogen phosphate and octane-1-sulfonic acid salt buffer and acetonitrile for the separation of analytes. According to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), the limit for determining the amount of active substances should be between 98% and 102%. With the developed method, the validation parameters were made according to the ICH Q2(R1) guideline. It has been seen that the method is a selective, precision and robustness method. Keywords: Benserazide Hydrochloride, HPLC, Assay, Validation
Author
Pelin Kaygu
How to Cite
Pelin Kaygu (Master Thesis). Development and validation of assay method for benserazide hydrochloride active ingredient, 2024, Tekirdağ Namık Kemal University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Tekirdağ Namık Kemal University
- The determination of factors that affect female labor force participation: Evidence from Turkey(2018)
- Evaluation of university campus areas in the context of urban design, Yeditepe University case study(2019)
- The predictive effect of hematological parameters on prognosis of non small cell metastatic lung cancer patients. namik kemal university faculty of medicine. internal medicine department. tekirdag(2016)
- Comparison of central cornea thickness data measured by ultrasonic pacimetry, specular microscopy and optic coherance tomography(2017)
- Comparison of elliptical and torsional phacoemulsification methods using the biaxial microincision technique(2017)
- Manufacturing of composite sandwich panel, and comparison of the panels manufactured according to failure criteria(2018)
